title: Ghrelin-induced orexigenic effect in rats depends on the metabolic status and is counteracted by peripheral CB1 receptor antagonism.
abstract: Ghrelin is an endogenous regulator of energy homeostasis synthesized by the stomach to stimulate appetite and positive energy balance. Similarly, the endocannabinoid system is part of our internal machinery controlling food intake and energy expenditure. Both peripheral and central mechanisms regulate CB1-mediated control of food intake and a functional relationship between hypothalamic ghrelin and cannabinoid CB1 receptor has been proposed. First of all, we investigated brain ghrelin actions on food intake in rats with different metabolic status (negative or equilibrate energy balance). Secondly, we tested a sub-anxiogenic ultra-low dose of the CB1 antagonist SR141716A (Rimonabant) and the peripheral-acting CB1 antagonist LH-21 on ghrelin orexigenic actions. We found that: 1) central administration of ghrelin promotes food intake in free feeding animals but not in 24 h food-deprived or chronically food-restricted animals; 2) an ultra-low dose of SR141716A (a subthreshold dose 75 folds lower than the EC50 for induction of anxiety) completely counteracts the orexigenic actions of central ghrelin in free feeding animals; 3) the peripheral-restricted CB1 antagonist LH-21 blocks ghrelin-induced hyperphagia in free feeding animals. Our study highlights the importance of the animaĺs metabolic status for the effectiveness of ghrelin in promoting feeding, and suggests that the peripheral endocannabinoid system may interact with ghrelińs signal in the control of food intake under equilibrate energy balance conditions.
authors.affiliation: Departamento de Psicobiología, Facultad de Psicología, Universidad Complutense de Madrid, Spain.
authors.forename: Francisco
authors.initials: F
authors.lastname: Alen
authors.forename: Inmaculada
authors.initials: I
authors.lastname: Crespo
authors.forename: María Teresa
authors.initials: MT
authors.lastname: Ramírez-López
authors.forename: Nadine
authors.initials: N
authors.lastname: Jagerovic
authors.forename: Pilar
authors.initials: P
authors.lastname: Goya
authors.forename: Fernando Rodríguez
authors.initials: FR
authors.lastname: de Fonseca
authors.forename: Raquel Gómez
authors.initials: RG
authors.lastname: de Heras
authors.forename: Laura
authors.initials: L
authors.lastname: Orio
mesh_terms: D000818:Animals; D004435:Eating / Q000187:drug effects; D054439:Ghrelin / Q000494:pharmacology*; D008297:Male; D010880:Piperidines / Q000494:pharmacology; D011720:Pyrazoles / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D043884:Receptor, Cannabinoid, CB1 / Q000037:antagonists & inhibitors* / Q000378:metabolism*; D000077285:Rimonabant; D014230:Triazoles / Q000494:pharmacology
chemical_list: C515162:5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-3-hexyl-1H-1,2,4-triazole; D054439:Ghrelin; D010880:Piperidines; D011720:Pyrazoles; D043884:Receptor, Cannabinoid, CB1; D014230:Triazoles; D000077285:Rimonabant
references.citation: Endocrinology. 2004 Jul;145(7):3224-31
references.pmid: 15033920
references.citation: Pharmacol Biochem Behav. 2010 Jun;95(4):375-82
references.pmid: 20347862
references.citation: Br J Pharmacol. 2004 Nov;143(5):520-3
references.pmid: 15381634
references.citation: Vitam Horm. 2008;77:121-48
references.pmid: 17983855
references.citation: Peptides. 2002 Mar;23(3):531-6
references.pmid: 11836003
references.citation: Nat Rev Endocrinol. 2009 Nov;5(11):633-8
references.pmid: 19844251
references.citation: Diabetes. 2001 Nov;50(11):2438-43
references.pmid: 11679419
references.citation: Br J Pharmacol. 2012 Apr;165(7):2274-91
references.pmid: 21951309
references.citation: Neuroreport. 1997 Jan 20;8(2):491-6
references.pmid: 9080435
references.citation: Br J Pharmacol. 2011 Aug;163(7):1423-31
references.pmid: 21434882
references.citation: J Pharmacol Sci. 2008 Nov;108(3):308-19
references.pmid: 19008645
references.citation: Gastroenterology. 2001 Feb;120(2):337-45
references.pmid: 11159873
references.citation: J Clin Endocrinol Metab. 2003 Jul;88(7):3450-3
references.pmid: 12843202
references.citation: Nature. 1999 Dec 9;402(6762):656-60
references.pmid: 10604470
references.citation: J Clin Endocrinol Metab. 2002 Jan;87(1):240-4
references.pmid: 11788653
references.citation: Neurosci Lett. 2009 Jan 2;449(1):20-3
references.pmid: 18926875
references.citation: J Neurosci. 2004 Mar 17;24(11):2708-15
references.pmid: 15028763
references.citation: Pharmacol Biochem Behav. 2011 Apr;98(2):220-6
references.pmid: 21163296
references.citation: Endocrinology. 2005 Aug;146(8):3518-25
references.pmid: 15890776
references.citation: Biochem Biophys Res Commun. 2001 Mar;281(5):1220-5
references.pmid: 11243865
references.citation: Endocr Metab Immune Disord Drug Targets. 2008 Sep;8(3):220-30
references.pmid: 18782018
references.citation: J Neurosci. 2001 Jul 15;21(14):5344-50
references.pmid: 11438610
references.citation: Neuroscience. 1991;44(3):655-62
references.pmid: 1721686
references.citation: J Neurosci. 2002 Nov 1;22(21):9612-7
references.pmid: 12417686
references.citation: J Biol Chem. 2006 Dec 15;281(50):38812-24
references.pmid: 17015451
references.citation: Diabetes Metab Res Rev. 2007 Oct;23(7):507-17
references.pmid: 17683024
references.citation: Nat Neurosci. 2005 May;8(5):585-9
references.pmid: 15856067
references.citation: J Biol Chem. 2011 Oct 28;286(43):37414-28
references.pmid: 21908614
references.citation: PLoS One. 2008 Mar 12;3(3):e1797
references.pmid: 18335063
references.citation: Psychopharmacology (Berl). 2001 Jan 1;153(2):267-70
references.pmid: 11205430
references.citation: Am J Physiol Endocrinol Metab. 2004 Aug;287(2):E297-304
references.pmid: 15039149
references.citation: Diabetologia. 2008 Mar;51(3):476-87
references.pmid: 18092149
references.citation: J Biol Chem. 2003 Jun 27;278(26):23731-7
references.pmid: 12690115
references.citation: Gastroenterology. 2002 Oct;123(4):1120-8
references.pmid: 12360474
references.citation: J Biol Chem. 2013 Jan 4;288(1):181-91
references.pmid: 23161547
references.citation: Int J Obes (Lond). 2009 May;33(5):541-52
references.pmid: 19238155
references.citation: Braz J Psychiatry. 2009 Jun;31(2):145-53
references.pmid: 19578688
references.citation: Nat Rev Neurosci. 2003 Nov;4(11):873-84
references.pmid: 14595399
references.citation: Diabetes. 2001 Aug;50(8):1714-9
references.pmid: 11473029
references.citation: J Pharmacol Exp Ther. 2010 Mar;332(3):710-9
references.pmid: 20016021
references.citation: Endocr Rev. 2006 Feb;27(1):73-100
references.pmid: 16306385
references.citation: J Psychopharmacol. 2012 Jan;26(1):114-24
references.pmid: 21824982
references.citation: Bioorg Med Chem Lett. 2008 May 1;18(9):2977-81
references.pmid: 18395444
references.citation: Neuropharmacology. 2006 Aug;51(2):358-66
references.pmid: 16750544
references.citation: Proc Natl Acad Sci U S A. 1995 Aug 1;92(16):7242-6
references.pmid: 7638174
references.citation: Neuropharmacology. 2004 Sep;47(4):593-603
references.pmid: 15380376
references.citation: Regul Pept. 2005 Mar 15;126(1-2):55-9
references.pmid: 15620414
references.citation: Neuropharmacology. 2008 Jan;54(1):219-25
references.pmid: 17889909
references.citation: J Biol Chem. 2005 Jul 1;280(26):25196-201
references.pmid: 15899896
references.citation: Neuropharmacology. 2008 Jan;54(1):206-12
references.pmid: 17675101
references.citation: Br J Nutr. 2004 Nov;92(5):757-61
references.pmid: 15533263
references.citation: Handb Exp Pharmacol. 2005;(168):299-325
references.pmid: 16596779
references.citation: J Endocrinol Invest. 2001 Jun;24(6):RC19-21
references.pmid: 11434675
references.citation: Nature. 2001 Apr 12;410(6830):822-5
references.pmid: 11298451
references.citation: Neurobiol Dis. 1998 Dec;5(6 Pt B):417-31
references.pmid: 9974175
references.citation: J Clin Endocrinol Metab. 2001 Oct;86(10):4753-8
references.pmid: 11600536
references.citation: Br J Pharmacol. 2004 Apr;141(8):1335-45
references.pmid: 15100166
references.citation: Am J Physiol Gastrointest Liver Physiol. 2006 Jun;290(6):G1289-97
references.pmid: 16423919
references.citation: J Neuroendocrinol. 2010 Nov;22(11):1127-36
references.pmid: 20807320
references.citation: Lancet. 2005 Apr 16-22;365(9468):1389-97
references.pmid: 15836887
references.citation: Nature. 2001 Jan 11;409(6817):194-8
references.pmid: 11196643
references.citation: J Neuroendocrinol. 2008 May;20 Suppl 1:116-23
references.pmid: 18426510
references.citation: Brain Res Mol Brain Res. 1997 Aug;48(1):23-9
references.pmid: 9379845